PeptideSwap

PeptideSwap is an emerging blockchain-based platform that aims to bring standardization, verification, and efficiency to the global peptide supply chain. According to its official whitepaper and a press release announcing its presale milestone, PeptideSwap operates as a decentralized finance (DeFi) ecosystem tailored for biotechnology commerce. The platform's native utility token, $PEPS, serves as the underlying layer for a peer-to-peer and business-to-business marketplace where peptide compounds can be listed and traded. A core feature of PeptideSwap is its verification-based marketplace, which requires stringent lot-level quality control, third-party laboratory verification, and analytical data tracking before any peptide compound is listed. This approach is designed to address trust and quality concerns in the peptide supply chain. Additionally, the platform includes a decentralized exchange (DEX) and swapping protocol that supports low-friction trading pairs between stablecoins, major cryptocurrencies, and $PEPS tokens. Automated liquidity infrastructure with dedicated liquidity pools is also part of the system, aimed at reducing price slippage. The project is currently in its presale phase, having crossed the US$30,000 capital milestone as of the press release dated October 11, 2026. PeptideSwap positions itself at the intersection of DeFi and biotechnology, targeting a niche real-world vertical. The platform is accessible via its website, www.PeptideSwap.com, where the whitepaper is also available. As a private, early-stage project, PeptideSwap's ownership and leadership details are not publicly disclosed in the available evidence.

PeptideSwap emerged as a project aiming to apply decentralized finance (DeFi) principles to the peptide supply chain. The platform's official whitepaper outlines a vision for a blockchain network specifically engineered to standardize, verify, and streamline global peptide commerce. As of October 11, 2026, the project was in its presale phase for the $PEPS token, having raised over US$30,000. The presale milestone was announced in a press release distributed via openPR.com, highlighting growing market appetite for niche real-world DeFi applications. The platform's development is focused on creating a verification-based marketplace, a decentralized exchange, and automated liquidity infrastructure. No further historical details, such as founding date or team background, are available in the provided evidence.

• PeptideSwap unveils whitepaper and announces $PEPS token presale surpassing US$30,000.

DeFi platform for verified peptide commerce, combining blockchain with biotechnology supply chain.

• $PEPS Token

  Native utility token serving as the underlying layer for the PeptideSwap marketplace and DEX.

• Verification-Based Marketplace

  A decentralized commerce protocol requiring lot-level quality control, third-party lab verification, and analytical data tracking before listing peptide compounds.

• Decentralized Exchange (DEX) & Swapping Protocol

  A tailored swapping module supporting low-friction trading pairs between stablecoins, major cryptocurrencies, and $PEPS tokens.

• Automated Liquidity Infrastructure

  Dedicated liquidity pools engineered to reduce price slippage.

1. 1PeptideSwap Unveils Whitepaper as Presale Tops $30Kopenpr.com
2. 2PeptideSwap Whitepaperpeptideswap.com